Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2007HaematologicaOpen Access

Ifosfamide, gemcitabine, and vinorelbine: a new induction regimen for refractory and relapsed Hodgkin's lymphoma

View Full Paper
Ask AI
Bookmark
Share

Authors

ASArmando SantoroMMMassimo MagagnoliMSMichele Spina

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Santoro et al. (2007) studied this question.

synapsesocial.com/papers/69ffc679b124fe5819859cf4https://doi.org/10.3324/haematol.10661
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Relapse in common lymphoma subtypes: salvage treatment options for follicular lymphoma, diffuse large cell lymphoma and Hodgkin disease2006 · 31 citations
  2. 2Effectiveness of high dose chemoradiotherapy and autologous stem cell transplantation for patients with biopsy‐proven primary refractory Hodgkin's disease2004 · 169 citations
  3. 3A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic model2001 · 428 citations
  4. 4Comparison Between Conventional Salvage Therapy and High-Dose Therapy With Autografting for Recurrent or Refractory Hodgkin's Disease1997 · 220 citations
  5. 5Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas1999 · 3,494 citations